NCT03270956View on ClinicalTrials.gov

A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 25, 2018

Primary Completion Date

November 17, 2022

Study Completion Date

November 17, 2022

Conditions
Type 2 Diabetes MellitusChronic Kidney Disease
Interventions
BIOLOGICAL

Renal Autologous Cell Therapy (REACT)

Autologous selected renal cells (SRC)

Trial Locations (4)

27599

University of North Carolina- Chapel Hill, Chapel Hill

37212

Vanderbilt University [WITHDRAWN], Nashville

83642

Boise Kidney & Hypertension Institute, Boise

85724

University of Arizona [WITHDRAWN], Tucson

Sponsors

Lead Sponsor

Prokidney
All Listed Sponsors
collaborator

CTI Clinical Trial and Consulting Services

OTHER

lead

Prokidney

INDUSTRY